Embryonic development of tendons is in close association with that of cartilage and bone. Although these tissues are derived from mesenchymal progenitor cells which also give rise to muscle and fat, their fates clearly diverse in early embryonic stages. Transcription factors may play pivotal roles in the process of determination and differentiation of tendon cells as well as other cells in the skeletal system. Scleruxis, a basic helix-loop-helix (bHLH) type transcription factor, is expressed in mesenchymal progenitors that later form connective tissues including tendons. Sox9 is an HMG-box containing transcription factor, which is expressed at high levels in chondrocytes. We hypothesized that the two transcription factors regulate the fate of cells that interact with each other at the interface between the two tissues during divergence of their differentiation pathways. To address this point, we investigated .scleraxis and Sox9 mRNA expression during mouse embyogenesis focusing on the coordinated development of tendons and skeletons. In the early stage of mesenchymal tissue development at 10.5 d.p.c., sclcruxis and Sox9 transcripts were expressed in thc mesenchymal progenitor cells in the appendicular and axial mesenchyme. At 11.5 d.p.c., sclrraxis transcripts were observed in the mesenchymal tissue surrounding skeletal primordia which express SoxY. From this stage, scleruxis expression was closely associated with, but distinct from, formation of skeletal primordia. At 13.5 d.p.c., scleruxis was expressed broadly in the interface between muscle and skeletal primordia while Sox9 expression is confined within the early skeletal primordia. Then, at 15.5 d.p.c., .sc,lm/si.s transcripts were more restricted to tendons. These observations revealed the presence of temporal and spatial association of sc1wtr.vi.s expression during embryonic development of tendon precursor cells in close association with that of Sox9 expression in chondrogenic cells in skeletal tissues.